The US Food and Drug Administration has granted fast-track designation to Moderna Inc.’s coronavirus vaccine candidate mRNA-1273.
The novel mRNA-based vaccine is one of the most advanced in the industry’s COVID-19 pipeline, making Moderna the center of...







